Table 3 Patient demographics of all inoperable patients with alveolar echinococcosis.
ID | Age | PNM | Initial clinical symptoms | Number of lesions | Size of biggest lesion (mm) | SUV ratio | FDG uptake pattern | CE score in CT | CE score in MRI | EMUC-CT | KODOMA | Duration* and status of follow-up (days) | Duration** and status of benzimidazole therapy (days) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
01 | 81 | P1 | N0 | M0 | None | 1 | 41 | 1.0 | Inhomogeneous | 1 | 1 | II− | 1 | 1621/alive | 1601/ongoing |
02 | 55 | P2 | N0 | M0 | Abdominal pain | 2 | 39 | 1.5 | Ringlike | 1 | 1 | II− | 2 | 1110/alive | 1131/ongoing |
03 | 57 | P4 | N1 | M0 | None | 1 | 62 | 1.7 | Ringlike | 2 | 3 | I+ | 1 | 921/dead1 | 1052/completed |
04 | 57 | P4 | N1 | M0 | Abdominal pain | 1 | 62 | 2.0 | Focal | 1 | 1 | II+ | 1 | 2488/alive | 2524/ongoing |
05 | 48 | P1 | N0 | M0 | None | 1 | 37 | 1.3 | Focal | na | na | II− | na | 3771/alive | 3621/ongoing |
06 | 64 | P4 | N1 | M0 | Abdominal pain | 15 | 42 | 2.0 | Focal | na | 4 | II+, IV | 2 | 1552/alive | 1544/ongoing |
07 | 38 | P3 | N0 | M0 | Jaundice | 1 | 31 | 1.6 | Inhomogeneous | na | 1 | II+ | 5 | 4340/alive | 2517/completed |
08 | 64 | P1 | N0 | M0 | None | 1 | 42 | 1.2 | Focal | 1 | na | II+ | na | 2177/alive | 74/completed |
09 | 46 | P4 | N1 | M1 | Edema | 2 | 73 | 2.8 | Ringlike | 2 | na | II+ | na | 3880/alive | 3898/ongoing |
10 | 59 | P3 | N1 | M0 | Diplopia | 6 | 124 | 1.8 | Inhomogeneous | 2 | na | II+ | na | 5508/alive | 5586/ongoing |
11 | 25 | P3 | N0 | M0 | na | > 50 | 44 | 1.2 | Inhomogeneous | na | na | I−, IV | na | 4570/alive | 1944/completed |
12 | 66 | P3 | N0 | M0 | Fever | 3 | 32 | 2.5 | Ringlike | 2 | 1 | II− | 3 | 2198/dead2 | 2206/ongoing |
13 | 87 | P3 | N0 | M0 | Abdominal pain | 8 | 121 | 2.0 | Ringlike | 2 | na | II+ | na | 1447/alive | 241/completed |
14 | 51 | P4 | N0 | M0 | Abdominal pain | 1 | 120 | 2.1 | Inhomogeneous | 2 | na | I− | na | 3726/alive | 3735/ongoing |
15 | 39 | P4 | N1 | M0 | Abdominal pain | 4 | 77 | 1.5 | Focal | 2 | 1 | II+ | 3 | 3852/alive | 3954/ongoing |
16 | 76 | P3 | N0 | M1 | None | 1 | 142 | 2.0 | Ringlike | 2 | na | II+ | na | 1105/dead3 | 1080/ongoing |
17 | 62 | P1 | N1 | M0 | None | 3 | 36 | 0.8 | No uptake | na | na | IIIA+ | na | 3559/alive | na |
18 | 75 | P1 | N0 | M0 | Abdominal pain | 20 | 49 | 0.6 | No uptake | na | na | IIIA, IV | na | 1835/alive | na |
19 | 62 | P4 | N1 | M0 | None | 1 | 132 | 1.9 | Ringlike | 1 | na | IIIB− | na | 883/dead4 | 749/ongoing |
20 | 60 | P1 | N0 | M0 | None | 9 | 43 | 0.6 | No uptake | na | 3 | II+, IV | 2 | 2092/alive | na |
21 | 67 | P3 | N1 | M0 | Abdominal pain | 2 | 95 | 3.2 | Inhomogeneous | 2 | 4 | II+ | 1 | 2096/alive | 2075/ongoing |
22 | 67 | P1 | N0 | M0 | None | 5 | 13 | 0.7 | No uptake | 1 | 1 | IV | 5 | 2150/alive | na |
23 | 32 | P4 | N1 | M0 | Abdominal pain | 4 | 61 | 3.6 | Inhomogeneous | 3 | na | II− | na | 1597/alive | 1633/ongoing |
24 | 41 | P2 | N1 | M0 | None | 1 | 107 | 2.5 | Ringlike | 2 | 3 | II+ | 3 | 945/alive | 945/ongoing |
25 | 72 | P4 | N1 | M1 | None | 1 | 184 | 4.6 | Ringlike | 2 | 4 | IIIB− | 3 | 1333/alive | 1328/ongoing |
26 | 77 | P2 | N1 | M1 | None | 2 | 78 | 3.7 | Inhomogeneous | 2 | 4 | I+ | 2 | 412/dead4 | 413/ongoing |
27 | 51 | P4 | N1 | M1 | Jaundice | 2 | 110 | 3.0 | Inhomogeneous | 3 | 4 | I+ | 3 | 938/alive | 927/ongoing |
28 | 63 | P2 | N0 | M0 | None | 2 | 27 | 1.3 | Inhomogeneous | na | 1 | II+ | 1 | 1958/alive | 565/completed |
29 | 71 | P1 | N0 | M0 | None | 1 | 67 | 2.6 | Ringlike | 2 | 1 | II+ | 3 | 1386/alive | 1325/ongoing |
30 | 28 | P1 | N0 | M1 | None | 4 | 25 | 1.3 | Ringlike | 1 | 3 | IV | 3 | 1427/alive | 721/ongoing |
31 | 57 | P4 | N1 | M1 | None | 17 | 84 | 3.8 | Ringlike | 4 | na | IV | na | 1422/alive | 1412/ongoing |
32 | 73 | P2 | N0 | M0 | None | 2 | 115 | 2.5 | Ringlike | 2 | 1 | II+ | 1 | 558/alive | 565/ongoing |
33 | 54 | P2 | N0 | M0 | None | 2 | 56 | 1.4 | Inhomogeneous | 1 | 3 | II+ | 1 | 554/alive | 542/ongoing |
34 | 56 | P2 | N1 | M0 | None | 1 | 77 | 1.1 | Ringlike | 1 | na | II− | na | 514/alive | 492/ongoing |
